Mutant KRAS promotes malignant pleural effusion formation.
Agalioti T, Giannou AD, Krontira AC, Kanellakis NI, Kati D, Vreka M, Pepe M, Spella M, Lilis I, Zazara DE, Nikolouli E, Spiropoulou N, Papadakis A, Papadia K, Voulgaridis A, Harokopos V, Stamou P, Meiners S, Eickelberg O, Snyder LA, Antimisiaris SG, Kardamakis D, Psallidas I, Marazioti A, Stathopoulos GT.
Agalioti T, et al. Among authors: kanellakis ni.
Nat Commun. 2017 May 16;8:15205. doi: 10.1038/ncomms15205.
Nat Commun. 2017.
PMID: 28508873
Free PMC article.